[Use of xidifon for prevention and treatment of nephropathies with metabolic disorders in children].
Xydofon was applied to the treatment of 68 children suffering from different renal diseases associated with metabolic disorders. The latter ones involved oxaluria (28 children), uraturia (17 children), cystinuria (14 children), and phosphaturia (9 children). To appraise the action of xydofon, use was made of the indicators of membranolysis, cellular homeostasis of calcium, lipid peroxidation, and of the level of beta 2-microglobulin in urine. The results obtained indicate that xydofon can be used as an effective remedy for the treatment of children suffering from nephropathies associated with metabolic disorders.
Korovina
N A
NA
Gavriushova
L P
LP
Iur'eva
E A
EA
Rzhevskaia
O N
ON
Mumladze
E B
EB
Tvorogova
T M
TM
Kulakova
G I
GI
Dunaeva
I P
IP
D000293:Adolescent; D002128:Calcium Metabolism Disorders / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D003555:Cystinuria / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D012968:Etidronic Acid; D006801:Humans; D006959:Hyperoxaluria / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D007674:Kidney Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D014527:Uric Acid / Q000652:urine
D004164:Diphosphonates; D014527:Uric Acid; D012968:Etidronic Acid
Ispol'zovanie ksidifona dlia profilaktiki i lecheniia dismetabolicheskikh nefropatiĭ u deteĭ.